Government Policy Makes Psychedelics Research ‘Extremely Hard,’ Top Federal Drug Official Says

Marijuana Moment
By Kyle JaegerApr 5, 2022, 4:12 pm296 pts
Top federal drug officials are again making clear that the Schedule I status of substances like marijuana and certain psychedelics is inhibiting valuable research into their therapeutic potential. Over the course of a two-day event last week organized by the National Academies of Sciences, Engineering and…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

We Need To Debunk Marijuana Rescheduling Myths As Trump Weighs Action (Op-Ed) 79

Using Cannabis Seeds During The Beer Brewing Process ‘Enhances The Nutritional Value,’ Study Shows 78

TerrAscend Renews, Replenishes $10M Share Repurchase Program 75

FLUENT Partners With Connected Cannabis at its New Cultivation Facility in New York 75

From ‘sin taxes’ to potency pricing: Modern approaches to excise tax policy 74

Study: Most Chronic Musculoskeletal Pain Cannabis Patients Stop Treatment Within One Year 71

US Must Legalize Marijuana And Expunge Drug Convictions To Meet ‘Moral Obligation’ Of ‘Justice For All,’ Congressional Resolution Says 68

Metrc Launches Direct-to-Consumer Product Recall Feature in California 66

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.